高阻隔材料
Search documents
研判2025!全球及中国EVOH行业生产工艺、供需现状及企业格局分析:产品供不应求,竞争格局高度集中,中国企业不断突破[图]
Chan Ye Xin Xi Wang· 2025-12-06 02:34
Core Insights - The article discusses the global market for Ethylene-Vinyl Alcohol Copolymer (EVOH), highlighting its production, consumption, and competitive landscape. EVOH is recognized as a key high-barrier material with significant applications in packaging and other industries. Industry Overview - EVOH, along with PVDC and PA, is one of the three major high-barrier materials globally. It is a random copolymer of ethylene and vinyl alcohol, known for its excellent gas barrier properties [2][3] - The production process of EVOH involves two main steps: polymerization and alcoholysis, with the first step producing EVA copolymer and the second converting it into EVOH [6][7] Production Capacity - As of the end of 2024, there are four companies globally producing EVOH, with a total capacity of approximately 214,500 tons per year. The production is concentrated in the USA, China, Belgium, and the UK [11][12] - The USA has the largest production capacity at 99,000 tons, accounting for 46.2% of the global total, followed by China with 42,500 tons (19.8%) [12] Consumption Trends - The global consumption of EVOH is projected to reach approximately 190,000 tons in 2024, with North America being the largest market, accounting for about 40% of total consumption [13][15] - In China, the consumption of EVOH is expected to be around 32,000 tons in 2024, with a compound annual growth rate of 5.8% from 2021 to 2024 [15][16] Competitive Landscape - The EVOH production market is highly concentrated, with only four companies capable of large-scale production: Kuraray, Mitsubishi Chemical, Changchun Group, and Sinopec Chuanwei. Kuraray and Mitsubishi Chemical together contribute over 80% of the total capacity [19] - In the Chinese market, Changchun Group holds a significant share, leveraging its cost advantage in general packaging materials, while Sinopec Chuanwei has recently entered the market with competitive products [19] Future Developments - Several companies in China are planning to establish new EVOH production facilities, with projects expected to be completed between 2025 and 2026, indicating a growing interest in expanding domestic production capabilities [20]
东峰集团: 东峰集团2024年年度股东大会会议资料(更新版)
Zheng Quan Zhi Xing· 2025-06-18 11:19
Meeting Overview - The shareholder meeting of Guangdong Dongfeng New Materials Group Co., Ltd. is scheduled for June 27, 2025, with specific procedures and rules established to ensure order and efficiency [1][2][3]. Meeting Agenda - The agenda includes the reading of meeting notices, introduction of attendees, and discussion of key proposals such as the 2024 annual report, profit distribution plan, and board of directors' work report [3][4][5]. Financial Performance - For the fiscal year 2024, the company reported a net loss attributable to shareholders of approximately RMB 489.49 million, a significant decline of 425.16% year-on-year [5][6]. - The total revenue for 2024 was RMB 1.42 billion, reflecting a 45.87% decrease compared to the previous year [6][7]. Strategic Focus - The company is undergoing a strategic transformation, focusing on new materials and Class I medical packaging, while gradually divesting from unrelated investments [6][28]. - The company aims to enhance its core business capabilities and improve cash flow management during this transition [29]. New Materials Business - The new materials segment is a key focus, with ongoing investments in the development of materials for energy storage and high-barrier applications [16][18]. - The company has made significant advancements in battery separator technology and has established partnerships for the development of solid-state battery materials [12][11]. Medical Packaging Sector - The Class I medical packaging sector has been prioritized, with the company consolidating its subsidiaries to strengthen its market position [17][19]. - Investments are being made in new manufacturing facilities to increase production capacity for medical packaging products [19][18]. Research and Development - The company has initiated multiple R&D projects aimed at developing high-performance materials and enhancing production processes [22][27]. - Collaborations with universities and industry leaders are being pursued to foster innovation and improve product offerings [21][20]. Corporate Governance - The board of directors has held multiple meetings to review and approve various proposals, ensuring compliance with corporate governance standards [30][32]. - The company emphasizes transparency in its operations, with regular disclosures made to stakeholders [34].